2m 2m 2m 2m 2m 2m 2m
Repligen (RGEN)
NASDAQ
$126.37-$0.20 (-0.16%)
Price as of Jun 23, 2026 4:13 PM EDT- $7.1BMarket Cap
- 5.38%1-Year Change
- Medical Instruments & SuppliesIndustry
Repligen (RGEN)
$126.37-$0.20 (-0.16%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 738.0M +16.32% | 634.4M +0.33% | 632.4M -21.11% | 801.5M +19.54% | |
Cost of Revenue | 352.0M -2.16% | 359.8M +1.66% | 353.9M +2.34% | 345.8M +23.83% | |
Gross Profit | 385.9M +40.53% | 274.6M -1.36% | 278.4M -38.90% | 455.7M +16.47% | |
Sales and Marketing Expense | 290.5M +10.30% | 263.4M +20.49% | 218.6M +1.28% | 215.8M +17.38% | |
Research and Development Expense | -54.2M +25.41% | -43.2M +1.12% | -42.7M -2.76% | -43.9M +28.19% | |
Depreciation and Amortization Expense | 78.7M +13.02% | 69.7M +1.63% | 68.6M +34.46% | 51.0M +32.61% | |
Total Operating Expenses | 683.1M +2.02% | 669.6M +14.52% | 584.7M +1.35% | 576.9M +14.62% | |
Operating Profit | 55.2M +257.11% | -35.1M -173.61% | 47.7M -78.77% | 224.7M +34.33% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | -22.6M N/A | N/A N/A | -2.0M +67.90% | -1.2M -90.86% | |
Interest Income and Expense and Net | -22.6M N/A | 0 +100.00% | -2.0M +67.90% | -1.2M -90.86% | |
Total Nonoperating Income and Expense | 7.2M -10.68% | 8.1M -10.27% | 9.0M +262.82% | -5.5M -59.65% | |
Income before Taxes | 62.4M +330.75% | -27.0M -147.67% | 56.7M -74.12% | 219.1M +42.72% | |
Income Taxes | 13.5M +986.85% | -1.5M -107.20% | 21.1M -36.38% | 33.2M +31.40% | |
Extraordinary Items | 0 N/A | 0 N/A | 0 N/A | N/A N/A | |
Net Income | 48.9M +291.64% | -25.5M -171.68% | 35.6M -80.86% | 186.0M +44.95% | |
Net Income from Continuing Operations Applicable to Common | 62.4M +330.75% | -27.0M -147.67% | 56.7M -74.12% | 219.1M +42.72% | |
Basic EPS and Net Income | 0.87 +289.13% | -0.46 -171.87% | 0.64 -80.90% | 3.35 +43.78% | |
Diluted EPS and Net Income | 0.86 +286.96% | -0.46 -173.02% | 0.63 -80.56% | 3.24 +44.64% | |
Basic Weighted Average Shares | 56,234 +0.53% | 55,937 +0.39% | 55,720 +0.47% | 55,460 -99.90% | |
Diluted Weighted Average Shares | 56,561 +1.12% | 55,937 -0.78% | 56,377 -1.88% | 57,455 -99.90% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 566.0M -25.26% | 757.4M +0.80% | 751.3M +43.53% | 523.5M -13.31% | |
Short-Term Investments | 201.6M N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 767.6M +1.36% | 757.4M +0.80% | 751.3M +43.53% | 523.5M -13.31% | |
Total Current Assets | 1.1B +6.69% | 1.1B -4.08% | 1.1B +11.34% | 998.1M +7.13% | |
Accumulated Depreciation | 203.9M +25.49% | 162.5M +26.21% | 128.7M +39.45% | 92.3M +30.53% | |
Property and Plant and Equipment and Net | 186.6M -5.63% | 197.7M -4.68% | 207.4M +8.79% | 190.7M +52.58% | |
Total Long-Term Assets | 1.8B +2.76% | 1.8B +2.55% | 1.7B +12.66% | 1.5B +7.00% | |
Total Assets | 2.9B +4.24% | 2.8B -0.05% | 2.8B +12.14% | 2.5B +7.05% | |
Income Taxes Payable | 3.6M +152.42% | 1.4M -79.12% | 6.8M +177.10% | 2.5M -55.16% | |
Total Short-Term Debt | N/A N/A | 0 -100.00% | 69.5M -75.60% | 284.6M +11.50% | |
Total Current Liabilities | 135.8M +7.13% | 126.8M -23.13% | 164.9M -59.19% | 404.2M +7.71% | |
Total Long-Term Debt | 542.2M +3.17% | 525.6M +3.02% | 510.1M -30.74% | 736.6M -21.12% | |
Total Long-Term Liabilities | 707.7M -3.07% | 730.2M +4.10% | 701.4M +234.38% | 209.8M -9.98% | |
Total Liabilities | 843.6M -1.56% | 856.9M -1.08% | 866.3M +41.11% | 614.0M +0.93% | |
Retained Earnings | 456.2M +12.00% | 407.4M -5.89% | 432.9M +8.96% | 397.3M +104.72% | |
Total Stockholders Equity | 2.1B +6.76% | 2.0B +0.40% | 2.0B +2.83% | 1.9B +9.18% | |
Total Shares Outstanding | 56.3M +0.42% | 56.1M +0.58% | 55.8M +0.38% | 55.6M +0.43% | |
Cash Flow | |||||
Cash from Operating Activities | 117.4M -33.06% | 175.4M +53.97% | 113.9M -33.80% | 172.1M +44.59% | |
Capital Expenditures | 23.5M -8.40% | 25.7M -29.11% | 36.2M -57.30% | 84.8M +26.45% | |
Cash from Investing Activities | -298.5M +245.52% | -86.4M -29.93% | -123.3M -47.15% | -233.2M +5.46% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -15.2M -81.66% | -82.9M -133.30% | 249.0M +1,966.69% | -13.3M -1,487.83% | |
Financials Ratio | |||||
Gross Margin | 52.30% +20.81% | 43.29% -1.69% | 44.03% -22.55% | 56.85% -2.56% | |
Operating Margin | 7.48% +235.07% | -5.53% -173.37% | 7.54% -73.09% | 28.03% +12.38% | |
Return on Assets | 1.69% +287.71% | -0.90% -167.82% | 1.33% -82.55% | 7.62% +26.49% | |
Return on Equity | 2.40% +285.00% | -1.30% -170.54% | 1.84% -81.92% | 10.16% +29.84% | |
Revenue Growth | 16.32% +4,867.09% | 0.33% +101.56% | -21.11% -208.03% | 19.54% -76.48% | |
Current Ratio | 8.37 -0.41% | 8.41 +24.79% | 6.74 +172.85% | 2.47 -0.54% | |
Cash Ratio | 4.17 -30.24% | 5.97 +31.14% | 4.56 +251.72% | 1.30 -19.51% | |
Debt-to-Equity Ratio | N/A N/A | 0.27 -9.69% | 0.30 -44.81% | 0.53 -21.33% | |
Debt-to-Assets Ratio | N/A N/A | 0.19 -9.28% | 0.20 -49.39% | 0.40 -19.77% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow